Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns

ClinicalTrials.gov ID: NCT02148705

Public ClinicalTrials.gov record NCT02148705. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 11:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Multinational, Randomized, Controlled, Assessor Blinded Study, Performed in Subjects With Thermal Burns, to Evaluate the Efficacy and Safety of NexoBrid Compared to Gel Vehicle and Compared to Standard of Care

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will be a three-arms study intending to demonstrate superiority of NexoBrid treatment over the Gel Vehicle placebo control treatment and over SOC in thermal burn subjects. The study objectives are: 1. To demonstrate the efficacy of enzymatic eschar removal with NexoBrid by providing complete eschar removal as compared with Gel vehicle, 2. To demonstrate the efficacy of enzymatic eschar removal with NexoBrid by providing earlier complete eschar removal, reduction in patients' surgical burden and its related blood loss as compared to SOC, 3. To assess the safety of NexoBrid compared to SOC, including demonstration that treatment with NexoBrid does not cause an unacceptable level of harm on wound closure outcome and long term outcomes of cosmesis and function.

Study identification

NCT ID
NCT02148705
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
MediWound Ltd
Industry
Enrollment
175 participants

Conditions and interventions

Conditions

Interventions

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years to 77 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 27, 2015 (Actual)
Primary completion
Jun 12, 2018 (Actual)
Completion
Aug 20, 2020 (Actual)
Last update posted
Jul 10, 2024

2015 – 2020

United States locations

U.S. sites
18
U.S. states
17
U.S. cities
18
Facility City State ZIP Site status
University of South Alabama Department of Surgery Mobile Alabama 36617 —
Maricopa Medical Center Phoenix Arizona 85008 —
University of Colorado at Denver, Teaching Aurora Colorado 80045 —
Medstar Washington Hospital Center Washington D.C. District of Columbia 20010 —
University of Florida- Dept. of Surgery Gainesville Florida 32610 —
Joseph M. Still Research Foundation, Inc. Augusta Georgia 30909 —
The University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
Burnett Burn Center at The University of Kansas Hospital Kansas City Kansas 66160 —
Johns Hopkins Bayview Medical Center Baltimore Maryland 8163 —
The General Hospital Corporation d/b/a Massachusetts General Hospital Boston Massachusetts 02114 —
New-York Presbyterian Hospital New York New York 10065 —
Emergency Medicine Stony Brook University Hospital Stony Brook New York 11794 —
Lehigh Valley Hospital and Health Network Allentown Pennsylvania 18103 —
Regional Medical Center ,Regional One Health Memphis Tennessee 38103 —
University of Texas Medical Branch Galveston Texas 77550 —
University of Utah Hospital Salt Lake City Utah 84132 —
HarborView Medical Center Seattle Washington 98104 —
Columbia St. Mary's, Inc. Milwaukee Wisconsin 53211 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02148705, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 10, 2024 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02148705 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →